House Investigates Drug Prices Amid Contributions from Pharmaceutical Industry

House members recently scrutinized rising prescription drug prices and the role of pharmacy benefit managers (PBMs) during a Capitol Hill hearing, raising concerns about their anti-competitive practices. Despite bipartisan criticism, lawmakers have received substantial campaign contributions from PBMs and pharmaceutical companies, highlighting potential conflicts of interest. In Alabama, local pharmacy support is growing as the Chambers County Commissioners passed a resolution against PBMs, emphasizing the importance of independent pharmacies in their community. Concurrently, Alabama's Senate Bill 93 aims to ensure fair reimbursement for pharmacies from PBMs, addressing funding challenges that threaten their viability. Lawmakers argue that PBMs can afford to provide better compensation without burdening consumers, as they are highly profitable. The ongoing legislative efforts reflect a broader push to reform pharmacy practices and support local pharmacies amid industry pressures.